Effect of Green Tea Extract on the Induction of Ornithine Decarboxylase and the Activation of Extracellular Signal-Regulated Kinase in Bladder Carcinoma ECV304 Cells

Nutrition and Cancer

Volumn 47, Issue 1, 2003, Pages 104-111

  Facchini, Annalisa ^a   Zanella, Barbara ^a   Stefanelli, Claudio ^a   Guarnieri, Carlo ^a   Flamigni, Flavio ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EPIGALLOCATECHIN GALLATE; GREEN TEA EXTRACT; MITOGEN ACTIVATED PROTEIN KINASE 1; ORNITHINE DECARBOXYLASE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BLADDER CARCINOMA; CANCER INHIBITION; CELL VIABILITY; CHEMOPROPHYLAXIS; CONTROLLED STUDY; DOSE RESPONSE; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INDUCTION; HUMAN; HUMAN CELL; WESTERN BLOTTING;

EID: 1342301611     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1207/s15327914nc4701_13     Document Type: Article

References (35)

1. Bushman JL: Green tea and cancer in humans: a review of the literature. J Nutr Cancer 31, 151-159, 1998.
2. Nagano J, Kono S, Preston DL, and Mabuchi K: A prospective study of green tea consumption and cancer incidence, Hiroshima and Nagasaki (Japan). Cancer Causes Control 12, 501-508, 2001.
3. Lu CM, Lan SJ, Lee YH, Huang JK, Huang CH, et al.: Tea consumption: fluid intake and bladder cancer risk in Southern Taiwan. Urology 54, 823-828, 1999.
4. Weisburger JH and Chung FL: Mechanisms of chronic disease causation by nutritional factors and tobacco products and their prevention by tea polyphenols. Food Chem Toxicol 40, 1145-1154, 2002.
5. Hu G, Han C, and Chen J: Inhibition of oncogene expression by green tea and (-)-epigallocatechin gallate in mice. J Nutr Cancer 24, 203-209, 1995.
6. Bachrach U and Wang, YC: Cancer therapy and prevention by green tea: role of ornithine decarboxylase. Amino Acids 22, 1-13, 2002.
7. Owuor E and Kong A: Antioxidants and oxidants regulated signal transduction pathways. Biochem Pharmacol 64, 765-770, 2002.
8. Agarwal R: Cell signaling and regulators of cell cycle as molecular targets for prostate cancer prevention by dietary agents. Biochem Pharmacol 60, 1051-1059, 2000.
9. Kennedy DO, Kojima A, Hasuma T, Yano Y, Otani S, et al.: Growth-inhibitory effect of green tea extract and (-)-epigallocatechin in Ehrlich ascites tumor cells involves a cellular thiol-dependent activation of mitogenic-activated protein kinases. Chem Biol Interact 134, 113-133, 2001.
10. Agarwal R, Katiyar SK, Zaidi SI, and Mukhtar H: Inhibition of skin tumor promoter-caused induction of epidermal ornithine decarboxylase in SENCAR mice by polyphenolic fraction isolated from green tea and its individual epicatechin derivatives. Cancer Res 52, 3582-3588, 1992.
11. Gupta S, Ahmad N, Mohan RR, Husain MM, and Muktar H: Prostate cancer chemoprevention by green tea: in vitro and in vivo inhibition of testosterone-mediated induction of ornithine decarboxylase. Cancer Res 59, 2115-2120, 1999.
12. Pegg AE: Polyamine metabolism and its importance in neoplastic growth and as a target for chemotherapy. Cancer Res 48, 759-774, 1988.
13. Pegg AE, Shantz LM, and Coleman CR: Ornithine decarboxylase as a target for chemoprevention. J Cell Biochem 22, 132-138, 1995.
14. Thomas T and Thomas TJ: Polyamines in cell growth and cell death: molecular mechanisms and therapeutic applications. Cell Mol Life Sci 58, 244-258, 2001.
15. Stefanelli C, Pignatti C, Tantini B, Fattori M, Stanic' I, et al.: Effect of polyamine depletion on caspase activation: a study with spermine synthase-deficient cells. Biochem J 355, 199-206, 2001.
16. Drexler HG, Quentmeier H, Dirks WG, and MacLeod RA: Bladder carcinoma cell line ecv304 is not a model for endothelial cells. In Vitro Cell Dev Biol Anim 38, 185-186, 2002.
17. Earnshaw WC, Martins LM, and Kaufmann SH: Mammalian caspases: structure, activation, substrates and functions during apoptosis. Annu Rev Biochem 68, 383-424, 1999.
18. Flamigni F, Facchini A, Giordano E, Tantini B, and Stefanelli C: Signaling pathways leading to the induction of ornithine decarboxylase: opposite effects of p44/42 mitogen-activated protein kinase (MAPK) and p38 MAPK inhibitors. Biochem Pharmacol 61, 25-32, 2001.
19. Stefanelli C, Bonavita F, Stanic' I, Mignani M, Facchini A, et al.: Spermine causes caspase activation in leukemia cells. FEBS Lett 437, 233-236, 1998.
20. Flamigni F, Facchini A, Capanni C, Stefanelli C, Tantini B, et al.: p44/42 mitogen-activated protein kinase is involved in the expression of ornithine decarboxylase in leukaemia L1210 cells. Biochem J 341, 363-369, 1999.
21. Tantini B, Pignatti C, Fattori M, Flamigni F, Stefanelli C, et al.: NF-kappaB and ERK cooperate to stimulate DNA synthesis by inducing ornithine decarboxylase and nitric oxide synthase in cardiomyocytes treated with TNF and LPS. FEBS Lett 512, 75-79, 2002.
22. Favata MF, Horiuchi KY, Manos EJ, Daulerio AJ, Stradley DA, et al.: Identification of a novel inhibitor of mitogen-activated protein kinase. J Biol Chem 273, 18623-18632, 1998.
23. Otieno MA and Kensler TW: A role for protein kinase C-δ in the regulation of ornithine decarboxylase expression by oxidative stress. Cancer Res 60, 4391-4396, 2000.
24. Gschwendt M, Muller HJ, Keilbassa K, Zang R, Kittstein W, et al.: Rottlerin, a novel protein kinase inhibitor. Biochem Biophys Res Commun 991, 93-98, 1994.
25. 2 Proc Natl Acad Sci USA 94, 11233-11237, 1997.
26. Guyton KZ, Gorospe M, Wang X, Mock YD, Kokkonen GC, et al.: Age-related changes in activation of mitogen-activated protein kinase cascades by oxidative stress. J Invest Dermatol Symp Proc 3, 23-27, 1998.
27. Shonwasser DC, Marais RM, Marshall CJ, and Parker PJ: Activation of mitogen-activated protein kinase/extracellular signal regulated kinase pathway by conventional, novel and atypical protein kinase C isotypes. Mol Cell Biol 18, 790-798, 1998.
28. Stefanelli C, Tantini B, Fattori M, Stanic' I, Pignatti C, et al.: Caspase activation in etoposide-xeated fibroblasts is correlated to ERK phosphorylation and both events are blocked by polyamine depletion. FEBS Lett 527, 223-228, 2002.
29. Kennedy DO, Kojima A, Yano Y, Otani S, and Matsui-Yuasa I: Growth inhibitory effect of green tea extract in Ehrlich ascites tumor cells involves cytochrome c release and caspase activation. Cancer Lett 166, 9-15, 2001
30. Tobias KE and Kahana C: Exposure to ornithine results in excessive accumulation of putrescine and apoptotic cell death in ornithine decarboxylase overproducing mouse myeloma cells. Cell Growth Differ 6, 1279-1285, 1995.
31. Packham G and Cleveland JL: Ornithine decarboxylase is a mediator of c-myc induced apoptosis. Mol Cell Biol 14, 5741-5747, 1994.
32. Monti MG, Ghiaroni S, Pernecco L, Barbieri D, Marverti G, et al.: Polyamine depletion protects HL-60 cells from 2-deoxy-D-ribose-induced apoptosis. Life Sci 62, 799-806, 1998.
33. Li L, Rao JN, Bass BL, and Wang, JY: NF-kappaB activation and susceptibility to apoptosis after polyamine depletion in intestinal epithelial cells. Am J Physiol Gastrointest Liver Physiol 280, G992-G1004, 2001.
34. Yuan Q, Ray RM, and Johnson LR: Polyamine depletion prevents camptothecin-induced apoptosis by inhibiting the release of cytochrome c. Am J Physiol Cell Physiol 282, C1290-C1297, 2002.
35. Yoo HG, Shin BA, Park JC, Kim HS, Chay KO, et al.: Induction of apoptosis by the green tea flavonol (-)-epigallocathekin-3-gallate in human endothelial ECV304 cells. Anticancer Res 22, 3373-3378, 2002.